Stuart Roberts

基本信息

浏览量：815

职业迁徙

个人简介

His main research interests are hepatocellular carcinoma, viral hepatitis, autoimmune hepatitis, fatty liver disease, and non-invasive markers of liver disease.
He has been Principal Investigator in over 165 sponsored and investigator-initiated clinical trials from phase I - IV. Professor Roberts has published more than 170 original articles across a range of high-impact journals including the New England Journal of Medicine, Lancet, Annals of Internal Medicine, Gastroenterology, Gut, Hepatology, and Journal of Hepatology.

研究兴趣

论文共 732 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Quality of Care in Hepatocellular Carcinoma-a Critical Review

Jonathan Abdelmalak,John S. Lubel,Marie Sinclair,Ammar Majeed,William Kemp,Stuart K. Roberts

HEPATOLOGY COMMUNICATIONSno. 1 (2025)

引用0浏览0WOS引用

The Asian Pacific Association for the Study of the Liver Clinical Practice Guidelines for the Diagnosis and Management of Metabolic Dysfunction-Associated Fatty Liver Disease

Mohammed Eslam,Jian-Gao Fan,Ming-Lung Yu,Vincent Wai-Sun Wong,Ian Homer Cua,Chun-Jen Liu,Tawesak Tanwandee,Rino Gani, Wai-Kay Seto,Shahinul Alam,Dan Yock Young,Saeed Hamid,Ming-Hua Zheng,Takumi Kawaguchi,Wah-Kheong Chan,Diana Payawal,Soek-Siam Tan,George Boon-bee Goh,Simone I. Strasser,Hang Dao Viet, Jia-Horng Kao,Won Kim,Seung Up Kim,Shelley E. Keating,Yusuf Yilmaz,Lubna Kamani,Chia-Chi Wang,Yasser Fouad,Zaigham Abbas,Sombat Treeprasertsuk,Kessarin Thanapirom,Mamun Al Mahtab, Undram Lkhagvaa,Oidov Baatarkhuu,Ashok Kumar Choudhury,Catherine A. M. Stedman,Abhijit Chowdhury,A Kadir Dokmeci,Fu-Sheng Wang,Han-Chieh Lin, Jee-Fu Huang,Jess Howell,Jidong Jia,Mohamed Alboraie,Stuart K. Roberts,Masato Yoneda,Hasmik Ghazinian, Aram Mirijanyan,Yuemin Nan,Cosmas Rinaldi Adithya Lesmana,Leon A. Adams,Gamal Shiha,Manoj Kumar,Necati Örmeci,Lai Wei,George Lau,Masao Omata, Shiv K. Sarin,Jacob George

Hepatology Internationalno. 2 (2025): 261-301

引用0浏览0WOS引用

Results from a Phase 2 Study of Triplet Blockade of the IL-27, PD-(L)1, and VEGF Pathways with Casdozokitug (casdozo, CHS-388) in Combination with Atezolizumab and Bevacizumab in Patients with Unresectable, Locally Advanced or Metastatic Hepatocellular Carcinoma (Uhcc)

Daneng Li,Kun-Ming Rau,Ming-Lung Yu,Hong Jae Chon,Meredith Pelster,Stuart K. Roberts,Oxana V. Crysler,Gina M. Vaccaro, Hyung-Don Kim, Koho Iizuka, Hong Tang, Varun N Kapoor,Daniel J Chin,Chih-Hung Hsu, Yoon-Koo Kang

Journal of Clinical Oncologyno. 4_suppl (2025): 605-605

引用0浏览0引用

Patient Reported Outcomes in Primary Sclerosing Cholangitis: an Australian Perspective

Natassia Tan, Christopher Zampogna, Kate Lynch,Nicholas Hannah,Siddharth Sood, Kate Collins,Avik Majumdar,Andrew Coulshed,Ken Liu,Rohit Sawhney,Stephen Bloom, John Lubel,William Kemp,Stuart Roberts,Ammar Majeed,Amanda J Nicoll

Alimentary pharmacology & therapeuticsno. 10 (2025): 1612-1621

引用0浏览0WOS引用

National Survey of Real-World Australian Treatment Patterns for Patients with Very-Early-To Intermediate-Stage Hepatocellular Carcinoma

Stuart K Roberts,Ammar Majeed, Kiran Rasaratnam,John K Olynyk,Nicholas Shackel,Marnie Wood,Simone I Strasser,Alan Wigg

Cancer medicineno. 5 (2025): e70722-e70722

引用0浏览0WOS引用

Opportunities to Improve Surveillance of Hepatocellular Carcinoma in Australia

Jess Howell, Jon D Emery,Stuart Roberts, Alexander J Thompson, Michael Ng,Jacob George, Barbara A Leggett,Edmund Tse, Bella Nguyen, Troy Combo, Alan J Wigg

The Medical journal of Australia (2025)

引用0浏览0WOS引用